Maxime Moulard

1.6k total citations
37 papers, 1.3k citations indexed

About

Maxime Moulard is a scholar working on Virology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Maxime Moulard has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Virology, 17 papers in Molecular Biology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Maxime Moulard's work include HIV Research and Treatment (21 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Immune Cell Function and Interaction (9 papers). Maxime Moulard is often cited by papers focused on HIV Research and Treatment (21 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Immune Cell Function and Interaction (9 papers). Maxime Moulard collaborates with scholars based in France, United States and Japan. Maxime Moulard's co-authors include Étienne Decroly, Quentin J. Sattentau, Isabelle Mondor, Richard T. Wyatt, Joseph Sodroski, Paul W.H.I. Parren, Dennis R. Burton, Hugues Lortat‐Jacob, Lu Zhao and William C. Olson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Maxime Moulard

34 papers receiving 1.3k citations

Peers

Countries citing papers authored by Maxime Moulard

Since Specialization

Citations

This map shows the geographic impact of Maxime Moulard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Moulard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Moulard more than expected).

Fields of papers citing papers by Maxime Moulard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Moulard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Moulard. The network helps show where Maxime Moulard may publish in the future.

Co-authorship network of co-authors of Maxime Moulard

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Moulard. A scholar is included among the top collaborators of Maxime Moulard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Moulard. Maxime Moulard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antiproliferative Effects of Naja anchietae and Naja senegalensis Venom Peptides on Glioblastoma Cell Lines 2024 ·Toxins ·(unknown), (unknown), (unknown), (unknown), Maxime Moulard, Pascal Mansuelle, Patrick Fourquet, F. Jason Torre, (unknown), Didier Gigmès, L’Houcine Ouafik, Kamel Mabrouk	1
2	How validated receptor occupancy flow cytometry assays can impact decisions and support drug development 2015 ·Cytometry Part B Clinical Cytometry ·Maxime Moulard, Marie‐Laure Ozoux	9
3	Reciprocal regulation of human platelet function by endogenous prostanoids and through multiple prostanoid receptors 2014 ·European Journal of Pharmacology ·(unknown), (unknown), Jens Timmer, Sabine Herterich, (unknown), Maxime Moulard, Ulrich Walter, Jörg Geiger	21
4	Comparison of a new ELISA assay with the flow cytometric assay for platelet vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation in whole blood to assess P2Y12 inhibition 2011 ·Thrombosis and Haemostasis ·(unknown), (unknown), Atsuhiro Sugidachi, Shinji Yamaguchi, Paul Barragan, Chunmei Zhou, Joseph A. Jakubowski, Maxime Moulard	16
5	Comparison of Cell Lysis Mediated by LFB-R603 with That Mediated by Ofatumumab Against Cells Expressing Low Levels of CD20, 2011 ·Blood ·Anne Bellon, Alain Sadoun, (unknown), Maxime Moulard, (unknown), Jean‐François Prost, Margarita Salcedo	3
6	Liposomal encapsulation enhances antiviral efficacy of SPC3 against human immunodeficiency virus type-1 infection in human lymphocytes 2002 ·Antiviral Research ·(unknown), Kamel Mabrouk, (unknown), Maxime Moulard, (unknown), Razika Oughideni, J. Van Rietschoten, Hervé Rochat, Michel De Waard, Jean‐Marc Sabatier	11
7	Heterogeneity of Envelope Molecules Expressed on Primary Human Immunodeficiency Virus Type 1 Particles as Probed by the Binding of Neutralizing and Nonneutralizing Antibodies 2002 ·Journal of Virology ·Pascal Poignard, Maxime Moulard, (unknown), (unknown), Michael Franti, Sara Venturini, Meng Wang, Paul W.H.I. Parren, Dennis R. Burton	156
8	Interferon-Independent, Human Immunodeficiency Virus Type 1 gp120-Mediated Induction of CXCL10/IP-10 Gene Expression by Astrocytes In Vivo and In Vitro 2001 ·Journal of Virology ·Valérie C. Asensio, (unknown), Richard Milner, Kaan Boztuǧ, Carrie Kincaid, Maxime Moulard, (unknown), (unknown), Thomas Krucker, Howard S. Fox, Iain L. Campbell	115
9	Ion channel activation by SPC3, a peptide derived from the HIV‐1 gp120 V3 loop 2000 ·Journal of Peptide Research ·Edmond Carlier, Michel De Waard, Kamel Mabrouk, Ziad Fajloun, Hervé Rochat, Jean‐Marc Sabatier, Maxime Moulard	8
10	Maturation of HIV envelope glycoprotein precursors by cellular endoproteases 2000 ·Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes ·Maxime Moulard, Étienne Decroly	116
11	Processing and routage of HIV glycoproteins by furin to the cell surface 1999 ·Virus Research ·Maxime Moulard, Sabine Hallenberger, Wolfgang Garten, Hans‐Dieter Klenk	42
12	V3 loop‐derived peptide SPC3 inhibits infection of CD4⁻ and galactosylceramide⁻ cells by LAV‐2/B 1999 ·Journal of Peptide Research ·Maxime Moulard, Kamel Mabrouk, J. Van Rietschoten, Hervé Rochat, Jean‐Marc Sabatier, Isabelle Martin	3
13	HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4 1997 ·The Journal of Immunology ·Sophie Ugolini, Maxime Moulard, Isabelle Mondor, Nicolas Barois, Denis Demandolx, James A. Hoxie, Anne Brelot, Marc Alizon, Jean Davoust, Quentin J. Sattentau	94
14	Anti-HIV Activity of Multibranched Peptide Constructs Derived either from the Cleavage Sequence or from the Transmembrane Domain (gp41) of the Human Immunodeficiency Virus Type 1 Envelope 1996 ·Virology ·Jean‐Marc Sabatier, Kamel Mabrouk, Maxime Moulard, Hervé Rochat, J. Van Rietschoten, Emmanuel Fenouillet	12
15	T4-lymphocyte endoprotease responsible for the proteolytic processing of HIV-1 GP160, like Kex2p endoprotease, is a calcium-dependent enzyme 1994 ·Biochimie ·Maxime Moulard, Tilman Achstetter, Yuzuru Ikehara, Elmostafa Bahraoui	4
16	Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor 1994 ·European Journal of Biochemistry ·Maxime Moulard, Tilman Achstetter, Marie‐Paule Kieny, Luc Montagnier, Elmostafa Bahraoui	9
17	Cytotoxic effect on lymphocytes of Tat from human immunodeficiency virus (HIV‐1) 1993 ·FEBS Letters ·Abdelaziz Benjouad, Kamel Mabrouk, Maxime Moulard, Jean‐Claude Gluckman, (unknown), (unknown), Jean‐Marc Sabatier	19
18	Crosslinking of Dam methyltransferase with S‐adenosyl‐methionine 1991 ·FEBS Letters ·(unknown), Maxime Moulard, Anders Løbner‐Olesen, Wilhelm Guschlbauer	15
19	Further studies on the human pancreatic binary complexes involving procarboxypeptidase A 1990 ·FEBS Letters ·Maxime Moulard, Thierry Michon, Brigitte Kerfélec, Catherine Chapus	8
20	Identification of a procarboxypeptidase A‐truncated protease E binary complex in human pancreatic juice 1989 ·FEBS Letters ·Maxime Moulard, Brigitte Kerfélec, Bernard Mallet, Catherine Chapus	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact